Ignite Creation Date:
2024-05-06 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 3:06 PM
Study NCT ID:
NCT06007690
Status:
RECRUITING
Last Update Posted:
2024-05-06
First Post:
2023-08-17
Brief Title:
A Phase 3 Randomized Masked Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan AU-011 Treatment Compared to Sham Control in Subjects with Primary Indeterminate Lesions or Small Choroidal Melanoma
Sponsor:
Aura Biosciences
Organization:
Aura Biosciences
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-17
First Submit QC Date:
August 17 2023
Study First Post Date:
2023-08-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-05-06
Last Update Post Date Type:
ACTUAL